General Gynecology · Cancer and Fertility

Long-term breast cancer risk following ovarian stimulation in young egg donors: a call for follow-up, research and informed consent

Schneider J, Lahl J, Kramer W

Published May 2017 Reproductive biomedicine online
DOI 10.1016/j.rbmo.2017.02.003 PMID 28473127

Abstract

In the USA and other countries, oocyte donation is gaining increasing importance. Although sufficient data exist on procedure-associated short-term risks for oocyte donors, such as ovarian hyperstimulation syndrome, long-term follow-up studies of egg donors are lacking and their health risks are unknown. The lack of information may be misleadingly interpreted as lack of risk. Long-term hormone replacement therapy is recognized as a risk factor for breast cancer; the breast cancer risk of ovarian stimulation for egg donors is unknown but is a possibility. This commentary describes five individual cases of egg donors who developed breast cancer (four out of five women in their 30s) despite negative genetic testing results. Additionally, we summarize available studies of breast cancer in infertile women who experienced IVF. We emphasize the need to create egg donor registries that will facilitate long-term studies on egg donors. Until this information is available, we call for more realistic explanations to egg donors about the lack of knowledge of long-term risks as well as more transparent informed consent documents.

Topics

By this author

Related research

General Gynecology › Cancer and Fertility › Hormone Sensitive Cancer and Reproductive Care · Assisted Reproduction › Safety and Risks › Procedure-Attributable Risk · Ethics and Policy › Informed Consent › Disclosure of Risks
Jennifer Schneider, Jennifer Lahl, Wendy Kramer
Jen Schneider, Jenny Schneider, J Schneider, Jen Lahl, Jenny Lahl, J Lahl, W Kramer
PMID 28473127 28473127 DOI 10.1016/j.rbmo.2017.02.003 10.1016/j.rbmo.2017.02.003 Schneider et al. 2017, Schneider 2017